Evidence Supports Denial Of Summary Judgment In Stock-Drop Suit, Investors Say
PHILADELPHIA — Class representatives asked a federal judge in Pennsylvania on July 14 to deny a motion for summary judgment on remaining federal securities laws claims brought against a generic drug...To view the full article, register now.
Already a subscriber? Click here to view full article